Table 2:
Association of GDF-15 with baseline clinical and biomarker variables
| Variable | Coefficient | 95% Confidence Limits | T | P-value |
|---|---|---|---|---|
| Log-2(hsTnT) | 0.18 | (0.12, 0.23) | 6.32 | <.0001 |
| Age, years | 0.01 | (0.01, 0.02) | 5.86 | <.0001 |
| Peak VO2, mL/kg/min | −0.04 | (−0.06, −0.03) | −5.69 | <.0001 |
| Log-2(creatinine) | 0.35 | (0.22, 0.48) | 5.25 | <.0001 |
| Log-2(NT-proBNP) | 0.08 | (0.05, 0.12) | 4.39 | <.0001 |
| LVEF, % | 0.01 | (0.007, 0.02) | 3.75 | 0.0002 |
| SBP, mmHg for values up to 125 | −0.008 | (−0.01, −0.003) | −3.49 | 0.0005 |
| SBP, mmHg for values above 125 | 0.008 | (0.002, 0.01) | 2.47 | 0.0136 |
| White race | 0.19 | (0.08,0.31) | 3.29 | 0.0011 |
| BMI, for values up to 35 | −0.02 | (−0.03,−0.008) | −3.20 | 0.0015 |
| Blood urea nitrogen (mg/dL) | 0.007 | (0.002, 0.01) | 2.98 | 0.0030 |
| Diabetes | 0.17 | (0.06, 0.28) | 2.96 | 0.0032 |
| Heart rate, beats per min | 0.006 | (0.001, 0.01) | 2.64 | 0.0086 |
| NYHA class III/IV | 0.12 | (0.01, 0.23) | 2.19 | 0.0292 |